FAQ

2-Bromoergocryptine Mesylate

Known as: Bromocriptine Mesylate, 2-Bromoergocryptine Mesylate [Chemical/Ingredient], Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)- 
The mesylate salt of bromocriptine, a semisynthetic ergot alkaloid with dopaminergic, antidyskinetic, and antiprolactinemic activities. Bromocriptine… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1957-2018
024619572017

Related topics

Related topics

19 relations
AcromegalyAmenorrheaBromocriptine 2.5 MG Oral Tablet [Parlodel]Bromocriptine 5 MG Oral Capsule [Parlodel]
(More)

Broader (1)

Bromocriptine

Narrower (2)

CyclosetParlodel

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
2-Bromoergocryptine Mesylate
Hypertensive disease
Parkinson Disease
Myocardial Ischemia
Pregnancy
Infertility

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats - a comparison.
Glutamatergic neurotransmission in the CNS plays a predominant role in learning and memory. While NMDA receptors have been… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
A specific role for the dopamine D3 receptor in behavior has yet to be elucidated. We now report that dopamine D2/D3 agonists… (More)
Is this relevant?
2005
2005
Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning.
Effects on aversive learning of the novel highly selective mGlu5 receptor antagonist [(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
BACKGROUND Patients with Parkinson disease (PD) treated with the nonergot dopamine agonists pramipexole dihydrochloride and… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation.
Using whole-cell patch-clamp methods, we examined the hypothesis that serotonin [5-hydroxytryptamine (5-HT)] receptor activation… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture.
The glomerular layer of the olfactory bulb (OB) contains synaptic connections between olfactory sensory neurons and OB neurons as… (More)
Is this relevant?
1998
1998
Synthesis and anticonvulsant activity of a new class of 2-[(arylalky)amino]alkanamide derivatives.
Although most epilepsies are adequately treated by conventional antiepileptic therapy, there remains an unfulfilled need for… (More)
Is this relevant?
1996
1996
Gelatin microspheres: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties.
The aim of this paper was to investigate the influence of preparation parameters on gelatin microspheres production, chemico… (More)
Is this relevant?
1987
1987
Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.
Amantadine hydrochloride and bromocriptine mesylate were compared on a double-blind basis for withdrawal from cocaine dependence… (More)
Is this relevant?
1982
1982
Surveillance of bromocriptine in pregnancy.
Information was collected on the outcome of 1,410 pregnancies in 1,335 women to whom bromocriptine mesylate (Parlodel) had been… (More)
Is this relevant?